1. Executive Summary |
2. Global Genetic Testing Market Introduction |
2.1. Global Genetic Testing Market – Taxonomy |
2.2. Global Genetic Testing Market –Definitions |
2.2.1. By Testing Type |
2.2.2. By Technology |
2.2.3. By Sample Type |
2.2.4. By Indication |
2.2.5. By Region |
3. Global Genetic Testing Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Genetic Testing Market Dynamic Factors – Impact Analysis |
3.6. Global Genetic Testing Market – Competition Landscape |
4. Global Genetic Testing Market Analysis, 2017-2021 and Forecast, 2022-2028 |
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Genetic Testing Market, By Testing Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.1. Predictive & Presymptomatic Testing |
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Carrier Testing |
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Prenatal & Newborn Testing |
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Diagnostic Testing |
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Pharmacogenomic Testing |
5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Others |
5.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
6. Global Genetic Testing Market, By Technology, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.1. Cytogenetic Testing |
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Biochemical Testing |
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Molecular Testing |
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Genetic Testing Market, By Sample Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.1. Blood |
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Saliva |
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Hair |
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Others |
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8. Global Genetic Testing Market, By Indication, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.1. Cancer |
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Cardiovascular Diseases |
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Neurological Diseases |
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Hematological Diseases |
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Rare Diseases |
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
8.6. Others |
8.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.6.3. Market Opportunity Analysis |
9. Global Genetic Testing Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.1. North America |
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia-Pacific |
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Latin America |
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Middle East and Africa |
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
9.6. Global Genetic Testing Market – Opportunity Analysis Index, By Testing Type, Technology, Sample Type, Indication, and Region, 2022-2028 |
10. North America Genetic Testing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
10.1. Testing Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Predictive & Presymptomatic Testing |
10.1.2. Carrier Testing |
10.1.3. Prenatal & Newborn Testing |
10.1.4. Diagnostic Testing |
10.1.5. Pharmacogenomic Testing |
10.1.6. Others |
10.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Cytogenetic Testing |
10.2.2. Biochemical Testing |
10.2.3. Molecular Testing |
10.3. Sample Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Blood |
10.3.2. Saliva |
10.3.3. Hair |
10.3.4. Others |
10.4. Indication Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Cancer |
10.4.2. Cardiovascular Diseases |
10.4.3. Neurological Diseases |
10.4.4. Hematological Diseases |
10.4.5. Rare Diseases |
10.4.6. Others |
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.5.1. USA |
10.5.2. Canada |
10.6. North America Genetic Testing Market – Opportunity Analysis Index, By Testing Type, Technology, Sample Type, Indication, and Country, 2022-2028 |
10.7. North America Genetic Testing Market Dynamics – Trends |
11. Europe Genetic Testing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
11.1. Testing Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Predictive & Presymptomatic Testing |
11.1.2. Carrier Testing |
11.1.3. Prenatal & Newborn Testing |
11.1.4. Diagnostic Testing |
11.1.5. Pharmacogenomic Testing |
11.1.6. Others |
11.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Cytogenetic Testing |
11.2.2. Biochemical Testing |
11.2.3. Molecular Testing |
11.3. Sample Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Blood |
11.3.2. Saliva |
11.3.3. Hair |
11.3.4. Others |
11.4. Indication Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Cancer |
11.4.2. Cardiovascular Diseases |
11.4.3. Neurological Diseases |
11.4.4. Hematological Diseases |
11.4.5. Rare Diseases |
11.4.6. Others |
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.5.1. Germany |
11.5.2. UK |
11.5.3. France |
11.5.4. Spain |
11.5.5. Italy |
11.5.6. Russia |
11.5.7. Rest of Europe |
11.6. Europe Genetic Testing Market – Opportunity Analysis Index, By Testing Type, Technology, Sample Type, Indication, and Country, 2022-2028 |
11.7. Europe Genetic Testing Market Dynamics – Trends |
12. Asia-Pacific Genetic Testing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
12.1. Testing Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Predictive & Presymptomatic Testing |
12.1.2. Carrier Testing |
12.1.3. Prenatal & Newborn Testing |
12.1.4. Diagnostic Testing |
12.1.5. Pharmacogenomic Testing |
12.1.6. Others |
12.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Cytogenetic Testing |
12.2.2. Biochemical Testing |
12.2.3. Molecular Testing |
12.3. Sample Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Blood |
12.3.2. Saliva |
12.3.3. Hair |
12.3.4. Others |
12.4. Indication Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Cancer |
12.4.2. Cardiovascular Diseases |
12.4.3. Neurological Diseases |
12.4.4. Hematological Diseases |
12.4.5. Rare Diseases |
12.4.6. Others |
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.5.1. China |
12.5.2. India |
12.5.3. Japan |
12.5.4. ASEAN |
12.5.5. Australia & New Zealand |
12.5.6. Rest of Asia-Pacific |
12.6. Asia-Pacific Genetic Testing Market – Opportunity Analysis Index, By Testing Type, Technology, Sample Type, Indication, and Country, 2022-2028 |
12.7. Asia-Pacific Genetic Testing Market Dynamics – Trends |
13. Latin America Genetic Testing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
13.1. Testing Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Predictive & Presymptomatic Testing |
13.1.2. Carrier Testing |
13.1.3. Prenatal & Newborn Testing |
13.1.4. Diagnostic Testing |
13.1.5. Pharmacogenomic Testing |
13.1.6. Others |
13.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.2.1. Cytogenetic Testing |
13.2.2. Biochemical Testing |
13.2.3. Molecular Testing |
13.3. Sample Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Blood |
13.3.2. Saliva |
13.3.3. Hair |
13.3.4. Others |
13.4. Indication Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Cancer |
13.4.2. Cardiovascular Diseases |
13.4.3. Neurological Diseases |
13.4.4. Hematological Diseases |
13.4.5. Rare Diseases |
13.4.6. Others |
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.5.1. Brazil |
13.5.2. Mexico |
13.5.3. Rest of Latin America |
13.6. Latin America Genetic Testing Market – Opportunity Analysis Index, By Testing Type, Technology, Sample Type, Indication, and Country, 2022-2028 |
13.7. Latin America Genetic Testing Market Dynamics – Trends |
14. Middle East and Africa Genetic Testing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
14.1. Testing Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.1.1. Predictive & Presymptomatic Testing |
14.1.2. Carrier Testing |
14.1.3. Prenatal & Newborn Testing |
14.1.4. Diagnostic Testing |
14.1.5. Pharmacogenomic Testing |
14.1.6. Others |
14.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.2.1. Cytogenetic Testing |
14.2.2. Biochemical Testing |
14.2.3. Molecular Testing |
14.3. Sample Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.3.1. Blood |
14.3.2. Saliva |
14.3.3. Hair |
14.3.4. Others |
14.4. Indication Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.4.1. Cancer |
14.4.2. Cardiovascular Diseases |
14.4.3. Neurological Diseases |
14.4.4. Hematological Diseases |
14.4.5. Rare Diseases |
14.4.6. Others |
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
14.5.1. Gulf Cooperation Council (GCC) Countries |
14.5.2. South Africa |
14.5.3. Rest of MEA |
14.6. MEA Genetic Testing Market – Opportunity Analysis Index, By Testing Type, Technology, Sample Type, Indication, and Country, 2022-2028 |
14.7. MEA Genetic Testing Market Dynamics – Trends |
15. Competition Landscape |
15.1. Strategic Dashboard of Top Market Players |
15.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis) |
15.2.1. 10X Genomics, Inc. |
15.2.2. Quest Diagnostics Incorporated |
15.2.3. QIAGEN N.V. |
15.2.4. Myriad Genetics Inc. |
15.2.5. Bio-Rad Laboratories Inc. |
15.2.6. F. Hoffmann-La Roche Ltd |
15.2.7. Eurofins Scientific |
15.2.8. Blueprint Genetics |
15.2.9. Illumina Inc. |
15.2.10. BGI Genomics |
15.2.11. PerkinElmer Inc. |
15.2.12. Abbott Laboratories |
15.2.13. Thermo Fisher Scientific Inc. |
16. Research Methodology |
17. Key Assumptions and Acronyms |